Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsadyn in Diabetic Neuropathic Foot Pain
NCT07260656Phase 1Recruiting
- Sponsor
- Carilion Clinic
- Start
- Nov 2025
- Primary completion
- Nov 2027
- Modality
- Transdermal Patches, Hydrogel Systems, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of capsaicin palmitate in diabetic peripheral neuropathy (DPN) (2 arms), sponsored by Carilion Clinic. Primary endpoint: Numeric Rating Scale for foot pain at 14 days. Started Nov 2025; status: recruiting.
02
Drugs
capsaicin palmitate
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT07260656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07260656.